1. Home
  2. KNSA vs CRCT Comparison

KNSA vs CRCT Comparison

Compare KNSA & CRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • CRCT
  • Stock Information
  • Founded
  • KNSA 2015
  • CRCT 1969
  • Country
  • KNSA United Kingdom
  • CRCT United States
  • Employees
  • KNSA N/A
  • CRCT N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • CRCT Wholesale Distributors
  • Sector
  • KNSA Health Care
  • CRCT Industrials
  • Exchange
  • KNSA Nasdaq
  • CRCT Nasdaq
  • Market Cap
  • KNSA 1.4B
  • CRCT 1.2B
  • IPO Year
  • KNSA 2018
  • CRCT 2021
  • Fundamental
  • Price
  • KNSA $20.02
  • CRCT $5.99
  • Analyst Decision
  • KNSA Strong Buy
  • CRCT Hold
  • Analyst Count
  • KNSA 5
  • CRCT 3
  • Target Price
  • KNSA $36.60
  • CRCT $5.25
  • AVG Volume (30 Days)
  • KNSA 567.6K
  • CRCT 254.4K
  • Earning Date
  • KNSA 02-25-2025
  • CRCT 03-04-2025
  • Dividend Yield
  • KNSA N/A
  • CRCT 10.02%
  • EPS Growth
  • KNSA N/A
  • CRCT 20.41
  • EPS
  • KNSA N/A
  • CRCT 0.29
  • Revenue
  • KNSA $384,098,000.00
  • CRCT $734,475,000.00
  • Revenue This Year
  • KNSA $60.10
  • CRCT N/A
  • Revenue Next Year
  • KNSA $34.22
  • CRCT N/A
  • P/E Ratio
  • KNSA N/A
  • CRCT $20.74
  • Revenue Growth
  • KNSA 54.41
  • CRCT N/A
  • 52 Week Low
  • KNSA $16.56
  • CRCT $4.43
  • 52 Week High
  • KNSA $28.15
  • CRCT $8.40
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 53.15
  • CRCT 59.92
  • Support Level
  • KNSA $19.31
  • CRCT $5.91
  • Resistance Level
  • KNSA $20.20
  • CRCT $5.74
  • Average True Range (ATR)
  • KNSA 0.80
  • CRCT 0.18
  • MACD
  • KNSA 0.06
  • CRCT 0.06
  • Stochastic Oscillator
  • KNSA 72.80
  • CRCT 93.14

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About CRCT Cricut Inc.

Cricut Inc designs and builds a creativity platform that enables users to turn ideas into professional-looking handmade goods. With its connected machines, design apps and accessories, and materials, the users create everything from personalized birthday cards, mugs, and T-shirts to large-scale interior decorations. It derives revenues from three segments including the Connected machines engaged in the sale of its connected machine hardware and related essential software, the Subscriptions segment provides monthly and annual subscription fees, and the Accessories and Materials segment provides craft, DIY, home decor products and heat presses including the Cricut EasyPress, Cricut Mug Press, and Cricut Autopress.

Share on Social Networks: